Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for thousands of patients with lung cancer driven by a rare type of KRAS mutation, offering hope for patients worldwide with this difficult-to-treat subtype of lung cancer.
Scientists uncover promising new way to treat an ‘undruggable’ type of lung cancer
calendar_today
July 7, 2026
domain
university-of-manchester